John Martin Docherty

All filings by John Martin Docherty on record concern Lexaria Bioscience Corp. In total, 6 filings cover trades dated from 15 April 2016 to 11 January 2021.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 12 January 2021 came the latest disclosure, a transaction in Lexaria Bioscience Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.